Answers are grounded in this paper and cite their sources.
Oncological therapies have become more selective and have low systemic toxicity because of their high specificity, but cutaneous side effects are common and may worsen the quality of life of these patients.
No takes yet. Share an insight, caveat, or question.
Fabbrocini et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: